Prolonged antibiotic administration for surgical site infection in pediatric laryngotracheal surgery

Michele Torre1, Irene Paraboschi2, Anna Loy3

  • 1Pediatric Surgery and Airway Team Unit, Scientific Institute for Research, Hospitalization, and Health Care, Istituto Giannina Gaslini, Genoa, Italy.

The Laryngoscope
|December 28, 2018
PubMed

Insights

A new antibiotic protocol significantly reduced surgical site infections (SSI) in pediatric laryngotracheal (LT) surgery. This tailored approach lowered SSI incidence from 36% to 4%, improving patient outcomes.

Area of Science:

  • Pediatric Surgery
  • Infectious Disease Management
  • Otolaryngology

Background:

  • Surgical site infections (SSI) pose a significant risk following laryngotracheal (LT) surgery, particularly in pediatric patients.
  • High incidence rates necessitate improved strategies to prevent SSIs in this vulnerable population.

Purpose of the Study:

  • To evaluate the impact of a new antibiotic management protocol on SSI incidence in children undergoing open LT surgery.
  • To compare SSI rates before and after the implementation of a tailored antibiotic strategy.

Main Methods:

  • Retrospective and prospective cohort study analyzing clinical records of 57 pediatric patients.
  • Comparison of SSI incidence between standard antibiotic prophylaxis and a new protocol involving pathogen-tailored, prolonged antibiotic treatment.
  • Univariate and multivariable analyses were used to identify risk factors and assess protocol effectiveness.

Main Results:

  • SSI incidence decreased dramatically from 36% with standard prophylaxis to 4% with the new protocol (P=.004).
  • The new strategy demonstrated an absolute benefit increase of 32% (95% CI: 11%-52%) in SSI prevention.
  • No significant differences in clinical conditions were observed between the groups, highlighting the protocol's specific impact.

Conclusions:

  • The implemented antibiotic management protocol significantly reduced the incidence of surgical site infections in pediatric laryngotracheal surgery.
  • This tailored, prolonged antibiotic approach represents a highly effective strategy for preventing SSIs in this surgical context.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
59.9K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296